Search

Cynthia A Oksanen

from Stonington, CT
Age ~63
Get Report
Also known as:
Cynthia An Oksanen, Cynthia A Sanen, Cynthtia Oksanen, Cynthia Oksanen Liston
Phone and address:
33 Kidds Way, Stonington, CT 06378
(860) 536-1749
Related to:
Jackie C Xenos, 74
Connected to:
Debra F Oksanen, 65Allan J Okscin, 73Brian R Oksen, 65Nancy R Okseniuk, 52Olga Oksman, 42Michael P Oksness, 43Anna L Oksnevad, 40Erik Oksnevad, 41Virginia C Oksten, 55Metin Oksuz, 62

Cynthia Oksanen Phones & Addresses

  • 33 Kidds Way, Stonington, CT 06378 (860) 536-1749
  • 11 Heath St, Mystic, CT 06355 (860) 536-1749
  • Groton, CT
  • Ledyard, CT
  • Madison, WI
  • Des Plaines, IL

Professional Records

License Records

Cynthia A Oksanen

Address:
Madison, WI 53703
License #:
051035324 - Expired
Issued Date:
Sep 5, 1984
Expiration Date:
Mar 31, 1990
Type:
Registered Pharmacist

Resumes

Resumes

Cynthia Oksanen Photo 1

Senior Director

View page
Location:
33 Kidds Way, Stonington, CT 06378
Industry:
Pharmaceuticals
Work:
Pfizer
Senior Director
Pfizer Apr 1992 - Dec 2012
Director
Pfizer Jun 2003 - Apr 2007
Director
Pfizer Mar 2002 - May 2003
Assistant Director
Pfizer 2001 - Mar 2002
Manager
Education:
University of Wisconsin-Madison 1986 - 1992
PhD, Pharmacy The University of Connecticut 1979 - 1984
BS, Pharmacy
Cynthia Oksanen Photo 2

Cynthia Oksanen

View page

Publications

Us Patents

Combination Dosage Form Comprising Cetirizine And Pseudoephedrine

View page
US Patent:
6537573, Mar 25, 2003
Filed:
Jan 5, 2001
Appl. No.:
09/755791
Inventors:
Barbara A. Johnson - Niantic CT
Richard W. Korsmeyer - Old Lyme CT
Cynthia A. Oksanen - Stonington CT
Assignee:
Pfizer Inc - New York NY
International Classification:
A61K 924
US Classification:
424472, 424480, 424490
Abstract:
A dosage form containing cetirizine as an immediate release component and pseudoephedrine or a pharmaceutically acceptable salt thereof as a controlled release component. A portion of the pseudoephedrine can also be incorporated as an immediate release component. The dosage form is free of alcohols having a molecular weight lower than 100 and reactive derivatives thereof.

Controlled-Release Of An Active Substance Into A High Fat Environment

View page
US Patent:
20040121015, Jun 24, 2004
Filed:
Dec 3, 2003
Appl. No.:
10/727217
Inventors:
Mark Chidlaw - Bend OR, US
Dwayne Friesen - Bend OR, US
Scott Herbig - East Lyme CT, US
James Nightingale - Bend OR, US
Cynthia Oksanen - Stonington CT, US
James West - Bend OR, US
Assignee:
Pfizer Inc
International Classification:
A61K009/24
US Classification:
424/471000
Abstract:
A controlled release delivery composition which can be administered to a high fat use environment such as the human gastrointestinal tract following a high fat meal. The delivery composition is embodied as a core surrounded by an asymmetric polymeric membrane. In a preferred embodiment, the asymmetric polymeric membrane is cellulose acetate.

Combination Dosage Form Comprising Cetirizine And Pseudoephedrine

View page
US Patent:
61716189, Jan 9, 2001
Filed:
May 28, 1997
Appl. No.:
8/864490
Inventors:
Barbara A. Johnson - Niantic CT
Richard W. Korsmeyer - Old Lyme CT
Cynthia A. Oksanen - Mystic CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 922
A61K 936
US Classification:
424472
Abstract:
A dosage form containing cetirizine as an immediate release component and pseudoephedrine or a pharmaceutically acceptable salt thereof as a controlled release component. A portion of the pseudoephedrine can also be incorporated as an immediate release component. The dosage form is free of alcohols having a molecular weight lower than 100 and reactive derivatives thereof.
Control profile
Cynthia A Oksanen from Stonington, CT, age ~63 Get Report